Sharps Technology, a major player in the medical technology industry, has announced a $400 million private investment in public equity (PIPE). This deal will help the company adopt a Solana (SOL) digital asset treasury strategy. This strategic move represents a significant shift in the company’s financial focus. The Sharps Solana Transaction The announcement includes the appointment of James Zhang as a strategic advisor and consultant. Zhang will work with three major crypto investment firms: Monarq Asset Management, ParaFi Capital, and Pantera Capital. These firms specialize in early-stage investments and innovative cryptocurrency strategies. Together, they will build and grow the Solana digital asset treasury. The company is confident in Solana’s ability to handle many transactions quickly and at low costs. Notably, the PIPE offering allows for the buying and selling of common stock and stapled warrants, which give the right to buy shares of common stock at $6.50 per unit. Investors who want to use locked or unlocked SOL to pay for their purchase will receive pre-funded warrants and stapled warrants. These warrants can be exercised as soon as the company gets approval from shareholders. Sharps Technology Aims to Close Deal Soon It is also worth noting that Sharps Technology is working with several investors, including Pantera, FalconX, Phoenix Capital, and others, to finalize the transaction. The company expects to close it on or around August 28, 2025. However, the deal requires approval from regulators and must meet other conditions. If everything goes well, Sharps Technology will be one of the first companies in the United States to establish the latest Solana treasury strategy. It hopes this strategy will help it grow faster and become a top medical manufacturing company in the region. Meanwhile, Sharps Technology plans to use the proceeds to buy SOL tokens from the open market. As such, creating a strong treasury strategy based on Solana that aligns with the increasing interest from Web3 and decentralized finance (DeFi) institutions. GSR Announces $100 Million Private Investment In April, GSR announced a $100 million private investment in public equity into Upexi , Inc., a consumer product firm. This fund was an avenue for the crypto trading firms to contribute to Upexi’s SOL treasury strategy. Recall that this was around the time when Upexi announced that it was pivoting toward a cryptocurrency-based treasury strategy. In a similar vein, Basel Medical Group, a Singapore-based healthcare provider, also took a bold step to enter crypto. As reported by TheCoinRise, the company had plans to buy $1 billion worth of Bitcoin (BTC) . The company believes adding Bitcoin to its reserves will help keep its finances balanced and flexible. The post Sharps Technology to Inject $400M Into Solana as Treasury Asset appeared first on TheCoinrise.com .
